Astrotide, LLC
- Biotech or pharma, therapeutic R&D
Astrotide leads Receptor.AI’s (www.receptor.ai) peptide drug discovery initiatives within its multiplatform ecosystem PharmaSphere™, drawing on years of experience in therapeutic peptide design and development.
Powered by state-of-the-art AI and in silico tools, our platform has been validated in over 40 collaborations with emerging biotechs and Big Pharma.
Leveraging the power of thePharmaSphere™ we are building a differentiated pipeline of best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, including oncology and immunology & inflammation.
At BIO 2025, we are exploring in-licensing, co-development, and discovery collaborations with biotech and pharma companies.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}